NO973515L - Anti-fedme proteiner - Google Patents

Anti-fedme proteiner

Info

Publication number
NO973515L
NO973515L NO973515A NO973515A NO973515L NO 973515 L NO973515 L NO 973515L NO 973515 A NO973515 A NO 973515A NO 973515 A NO973515 A NO 973515A NO 973515 L NO973515 L NO 973515L
Authority
NO
Norway
Prior art keywords
obesity
obesity proteins
proteins
diabetes
silk
Prior art date
Application number
NO973515A
Other languages
English (en)
Other versions
NO973515D0 (no
Inventor
Margaret B Basinski
Richard D Dimarchi
David B Flora
John E Hale
Jr William Francis Heath
James Arthur Hoffmann
Brigitte E Schoner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/000952 external-priority patent/WO1996023517A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO973515D0 publication Critical patent/NO973515D0/no
Publication of NO973515L publication Critical patent/NO973515L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse beskriver antl-fedmeprotelner, som når de blir administrert til en pasient regulerer fettvev. Silke midler tillater pasienter å overvinne deres fedmehandicap og leve normale liv med redusert risiko for type II diabetes, kardlovaskulær sykdom og cancer.
NO973515A 1995-01-31 1997-07-30 Anti-fedme proteiner NO973515L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38104895A 1995-01-31 1995-01-31
US38363895A 1995-02-06 1995-02-06
US45095P 1995-06-22 1995-06-22
US216195P 1995-08-11 1995-08-11
PCT/US1996/000952 WO1996023517A1 (en) 1995-01-31 1996-01-29 Anti-obesity proteins

Publications (2)

Publication Number Publication Date
NO973515D0 NO973515D0 (no) 1997-07-30
NO973515L true NO973515L (no) 1997-09-29

Family

ID=27484996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973515A NO973515L (no) 1995-01-31 1997-07-30 Anti-fedme proteiner

Country Status (15)

Country Link
JP (1) JPH10513451A (no)
KR (1) KR19980701798A (no)
AR (1) AR002956A1 (no)
AU (1) AU703316B2 (no)
BR (1) BR9606999A (no)
CA (1) CA2211784A1 (no)
CO (1) CO4480035A1 (no)
CZ (1) CZ240497A3 (no)
FI (1) FI973162A (no)
NO (1) NO973515L (no)
NZ (1) NZ301589A (no)
PE (1) PE15197A1 (no)
PL (1) PL321702A1 (no)
TR (1) TR199600085A2 (no)
YU (1) YU5296A (no)

Also Published As

Publication number Publication date
PE15197A1 (es) 1997-05-22
JPH10513451A (ja) 1998-12-22
AU4705296A (en) 1996-08-21
BR9606999A (pt) 1997-10-28
FI973162A0 (fi) 1997-07-30
FI973162A (fi) 1997-09-30
CA2211784A1 (en) 1996-08-08
TR199600085A2 (tr) 1996-08-21
AU703316B2 (en) 1999-03-25
YU5296A (sh) 1998-08-14
PL321702A1 (en) 1997-12-22
NO973515D0 (no) 1997-07-30
CO4480035A1 (es) 1997-07-09
KR19980701798A (ko) 1998-06-25
NZ301589A (en) 1999-02-25
CZ240497A3 (cs) 1998-01-14
AR002956A1 (es) 1998-05-27

Similar Documents

Publication Publication Date Title
BR0011891A (pt) Composto, composição farmacêutica, uso de um composto, métodos para tratamento de uma doença ou condição mediada pelo hpparso , para diminuir triglicerìdios em um paciente, para tratar a diabete do tipo 2, diminuir a resistência à insulina ou abaixar a pressão sanguìnea em um paciente, para diminuir os nìveis de fribogênio em um paciente, para diminuir o ldlc em um paciente e para mudar o tamanho da partìcula do ldl denso pequeno para denso normal em um paciente, e , uso de uma agonista hpparso
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
AU2002351593A1 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
PA8453501A1 (es) Derivados dipeptidicos
TW200711657A (en) Pharmaceutical composition comprising botulinum toxin and recombinant human serum albumin
IL149147A0 (en) Use of oxcarbazepine for the manufacture of oral dosage form medicament
BR9913645A (pt) Terapias combinadas para linfomas de células b compreendendo a administração de anticorpo anti-cd20
WO2003062273A3 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
TR199902980T2 (xx) Diabetin tedavisi i�in leptin antagonistlerinin kullan�m�.
NO975938L (no) Anti-fedme proteiner
DK1525215T3 (da) Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner
NO973515L (no) Anti-fedme proteiner
IT1317927B1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
DK1037629T3 (da) Kombination af et retinsyremetabolismeblokerende middel og en tocopherol
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn
IT1317930B1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
MD970254A (en) Use of melatonine for treatment of patients having a medicamental dependence
ATE214935T1 (de) Robinia pseudoacacia lektin und seine verwendungen
ES2181923T3 (es) 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
MXPA03011186A (es) Uso de pentraxina ptx3 de cadena larga para tratamiento contra enfermedades tumorales mediadas por fgf-8.
BR0206361A (pt) Método de terapia de reposição de hormÈnio e sua forma de administração
MX9705832A (es) Proteinas contra la obesidad.
ECSP961650A (es) Proteinas anti- obesidad (caso x-9926a)
ECSP961649A (es) Proteinas anti-obesidad (caso x 10180m)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application